Publicaciones

• Structural inequality and temporal brain dynamics across diverse samples. Baez, S., Hernandez, H., Moguilner, S., Cuadros, J., Santamaria-Garcia, H., Medel, V., Migeot, J., Cruzat, J., Valdes-Sosa, P. A., Lopera, F., González-Hernández, A., Bonilla-Santos, J., Gonzalez-Montealegre, R. A., Aktürk, T., Legaz, A., Altschuler, F., Fittipaldi, S., Yener, G. G., Escudero, J., Babiloni, C., Duran-Aniotz, C. … Ibanez, A. (2024). Clinical and translational medicine, 14(10), e70032. doi: 10.1002/ctm2.70032

• Biomarkers of neurodegeneration across the Global South. McGlinchey, E., Duran-Aniotz, C., Akinyemi, R., Arshad, F., Zimmer, E. R., Cho, H., Adewale, B. A., & Ibanez, A. (2024). The lancet. Healthy longevity, 100616. doi: 10.1016/S2666-7568(24)00132-6

• Brain clocks capture diversity and disparities in aging and dementia across geographically diverse populations. Moguilner, S., Baez, S., Hernandez, H., Migeot, J., Legaz, A., Gonzalez-Gomez, R., Farina, F. R., Prado, P., Cuadros, J., Tagliazucchi, E., Altschuler, F., Maito, M. A., Godoy, M. E., Cruzat, J., Valdes-Sosa, P. A., Lopera, F., Ochoa-Gómez, J. F., Hernandez, A. G., Bonilla-Santos, J., Gonzalez-Montealegre, R. A., Duran-Aniotz, C., … Ibanez, A. (2024). Nature medicine, doi:10.1038/s41591-024-03209-x

• Healthy aging meta-analyses and scoping review of risk factors across Latin America reveal large heterogeneity and weak predictive models. Ibanez, A., Maito, M., Botero-Rodríguez, F., Fittipaldi, S., Coronel, C., Migeot, J., Lacroix, A., Lawlor, B., Duran-Aniotz, C., Baez, S., & Santamaria-Garcia, H. (2024). Nature aging, 4(8), 1153–1165 doi: 10.1038/s43587-024-00648-6.

• Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer’s Association International conference satellite symposium in Mexico City. Sosa, A. L., Brucki, S. M., Crivelli, L., Lopera, F. J., Acosta, D. M., Acosta-Uribe, J., Aguilar, D., Aguilar-Navarro, S. G., Allegri, R. F., Bertolucci, P. H., Calandri, I. L., Carrillo, M. C., Mendez, P. A. C., Cornejo-Olivas, M., Custodio, N., Damian, A., de Souza, L. C., Duran-Aniotz, C., García, A. M., García-Peña, C., … Sexton, C. (2024). Alzheimer’s & dementia : the journal of the Alzheimer’s Association, 20(7), 5009–5026 doi: 10.1002/alz.13850.

• Neuroecological links of the exposome and One Health. Ibanez, A., Melloni, L., Świeboda, P., Hynes, W., Ikiz, B., Ayadi, R., Thioye, M., Walss-Bass, C., Güntekin, B., Mishra, J., Salama, M., Dunlop, S., Duran-Aniotz, C., & Eyre, H. A. (2024). Neuron, 112(12), 1905–1910 doi: 10.1016/j.neuron.2024.04.016

• Allostasis, health, and development in Latin America. Migeot, J., Panesso, C., Duran-Aniotz, C., Ávila-Rincón, C., Ochoa, C., Huepe, D., Santamaría-García, H., Miranda, J. J., Escobar, M. J., Pina-Escudero, S., Romero-Ortuno, R., Lawlor, B., Ibáñez, A., & Lipina, S. (2024). Neuroscience and biobehavioral reviews, 162, 105697, doi: 10.1016/j.neubiorev.2024.105697

• Long-Term Survival and Immune Response Dynamics in Melanoma Patients Undergoing TAPCells-Based Vaccination Therapy. Tittarelli, A., Pereda, C., Gleisner, M. A., López, M. N., Flores, I., Tempio, F., Lladser, A., Achour, A., González, F. E., Duran-Aniotz, C., Miranda, J. P., Larrondo, M., & Salazar-Onfray, F. (2024). Vaccines, 12(4), 357. doi:10.3390/vaccines12040357

• miRNAs peripheral biomarkers for early diagnosis of AD in Latinamerican population. Orellana, P., Caviedes, A., Gonzalez, C., Salcidua, S., Henriquez, F., Cabello, V., Lillo, P., Villagra, R., Cerda, M., Zitko, P., Thumala, D., Gonzalez, C., Ibanez, A., de la Cruz, R., Slachevsky, A. and Duran-Aniotz, C. (2023) Alzheimer’s & dementia, 19: e076778. doi: 10.1002/alz.076778

• Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer’s disease. Blanco, K., Salcidua, S., Orellana, P., Sauma-Pérez, T., León, T., Steinmetz, L. C. L., Ibañez, A., Duran-Aniotz, C., & de la Cruz, R. (2023). Alzheimer’s research & therapy, 15(1), 176. doi: 10.1186/s13195-023-01304-8.

• Latin American women in dementia research: outstanding contributions, barriers, and opportunities from Argentinian, Chilean, and Colombian colleagues. Fittipaldi, S., Baez, S., Gonzalez-Silva, C., & Duran-Aniotz, C. (2023). Frontiers in aging neuroscience, 15, 1168414.. doi: 10.3389/fnagi.2023.1168414.

• The unfolded protein response transcription factor XBP1s ameliorates Alzheimer’s disease by improving synaptic function and proteostasis. Duran-Aniotz, C., Poblete, N., Rivera-Krstulovic, C., Ardiles, Á. O., Díaz-Hung, M. L., Tamburini, G., Sabusap, C. M. P., Gerakis, Y., Cabral-Miranda, F., Diaz, J., Fuentealba, M., Arriagada, D., Muñoz, E., Espinoza, S., Martinez, G., Quiroz, G., Sardi, P., Medinas, D. B., Contreras, D., Piña, R., … Hetz, C. (2023). Molecular therapy : the journal of the American Society of Gene Therapy, 31(7), 2240–2256. doi: 10.1016/j.ymthe.2023.03.028.

• Promoting diversity and overcoming publication barriers in Latin American neuroscience and Alzheimer’s disease research: A call to action. Lourenco, M. V., Borelli, W. V., Duran-Aniotz, C., Zimmer, E. R., & de Castro, S. S. (2023). Alzheimer’s & dementia (New York, N. Y.), 9(1), e12378. doi: 10.1002/trc2.12378.

• Genetic overlap between cortical brain morphometry and frontotemporal dementia risk. Diaz-Torres, S., Ogonowski, N., García-Marín, L. M., Bonham, L. W., Duran-Aniotz, C., Yokoyama, J. S., & Rentería, M. E. (2023). Cerebral cortex (New York, N.Y. : 1991), 33(12), 7428–7435. doi: 10.1093/cercor/bhad049.

• Unfolded protein response IRE1/XBP1 signaling is required for healthy mammalian brain aging. Cabral-Miranda, F., Tamburini, G., Martinez, G., Ardiles, A. O., Medinas, D. B., Gerakis, Y., Hung, M. D., Vidal, R., Fuentealba, M., Miedema, T., Duran-Aniotz, C., Diaz, J., Ibaceta-Gonzalez, C., Sabusap, C. M., Bermedo-Garcia, F., Mujica, P., Adamson, S., Vitangcol, K., Huerta, H., Zhang, X., … Hetz, C. (2022). The EMBO journal, 41(22), e111952. doi: 10.15252/embj.2022111952.

• The burden of mild cognitive impairment attributable to physical inactivity in Colombia. O’Donovan, G., Lee, I. M., Hamer, M., García-Garro, P., Duran-Aniotz, C., Ibáñez, A., Sarmiento, O. L., & Hessel, P. (2022). European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity, 19(1), 28. doi: 10.1186/s11556-022-00307-y

• Associations of body mass index and sarcopenia with screen-detected mild cognitive impairment in older adults in Colombia. O’Donovan, G., Sarmiento, O. L., Hessel, P., Muniz-Terrera, G., Duran-Aniotz, C., and Ibáñez, A. Frontiers in Nutrition. 2022, 9. doi: 10.3389/fnut.2022.1011967

• Associations of body mass index and sarcopenia with screen-detected mild cognitive impairment in older adults in Colombia. O’Donovan, G., Sarmiento, O. L., Hessel, P., Muniz-Terrera, G., Duran-Aniotz, C., and Ibáñez, A. Frontiers in Nutrition. 2022, 9. doi: 10.3389/fnut.2022.1011967

• Biomarkers for dementia in Latin American countries: Gaps and opportunities. Parra MA, Orellana P, Leon T, Victoria CG, Henriquez F, Gomez R, Avalos C, Damian A, Slachevsky A, Ibañez A, Zetterberg H, Tijms BM, Yokoyama JS, Piña-Escudero SD, Cochran JN, Matallana DL, Acosta D, Allegri R, Arias-Suárez BP, Barra B, Behrens MI, Brucki SMD, Busatto G, Caramelli P, Castro-Suarez S, Contreras V, Custodio N, Dansilio S, la Cruz-Puebla M, de Souza LC, Diaz MM, Duque L, Farías GA, Ferreira ST, Guimet NM, Kmaid A, Lira D, Lopera F, Meza BM, Miotto EC, Nitrini R, Nuñez A, O’Neill S, Ochoa J, Pintado-Caipa M, Resende EPF, Risacher S, Rojas LA, Sabaj V, Schilling L, Sellek AF, Sosa A, Takada LT, Teixeira AL, Unaucho-Pilalumbo M, Duran-Aniotz C. Alzheimers Dement. 2022 Sep 13. doi: 10.1002/alz.12757. Epub ahead of print. PMID: 36098676.

• A predictive coding framework of allostatic-interoceptive overload in frontotemporal dementia. Migeot JA, Duran-Aniotz CA, Signorelli CM, Piguet O, Ibáñez A. Trends Neurosci. 2022 Nov;45(11):838-853. doi: 10.1016/j.tins.2022.08.005. Epub 2022 Sep 1. PMID: 36057473.

• The Latin American Brain Health Institute, a regional initiative to reduce the scale and impact of dementia. Duran-Aniotz, C., Sanhueza, J., Grinberg, L.T., Slachevsky, A., Valcour, V., Robertson, I., Lawlor, B., Miller, B., Ibáñez, A. Alzheimers Dement. 2022 Jun 16. doi: 10.1002/alz.12710. Epub ahead of print. PMID: 35708193.

• Neuronal Rubicon Represses Extracellular APP/Amyloid β Deposition in Alzheimer’s Disease. Espinoza S, Grunenwald F, Gomez W, García F, Abarzúa-Catalan L, Oyarce-Pezoa S, Hernandez MF, Cortés BI, Uhrig M, Ponce DP, Durán-Aniotz C, Hetz C, SanMartín CD, Cornejo VH, Ezquer F, Parra V, Behrens MI, Manque PA, Rojas-Rivera D, Vidal RL, Woehlbier U, Nassif M. Cells. 2022 Jun 7;11(12):1860. doi: 10.3390/cells11121860. PMID: 35740989; PMCID: PMC9221152.

• Multiscale entropy analysis of retinal signals reveals reduced complexity in a mouse model of Alzheimer’s disease. Araya-Arriagada, J., Garay, S., Rojas, C., Duran-Aniotz, C., Palacios, A.G., Chacón, M., Medina. L.E. Sci Rep. 2022 May 25;12(1):8900. doi: 10.1038/s41598-022-12208-2. PMID: 35614075; PMCID: PMC9132967.

• Allostatic interoceptive overload in frontotemporal dementia. Birba, A., Santamaría-García, H., Prado, P., Cruzat, J., Ballesteros, A.S., Legaz, A., Fittipaldi, S., Duran-Aniotz, C., Slachevsky, A., Santibañez, R., Sigman, M., García, A.M., Whelan, R., Moguilner, S., Ibáñez, A. Biol Psychiatry. 2022 Jul 1;92(1):54-67. doi: 10.1016/j.biopsych.2022.02.955. Epub 2022 Feb 24. PMID: 35491275.

• Editorial: Protein Misfolding and Proteostasis Impairment in Aging and Neurodegeneration: From Spreading Studies to Therapeutic Approaches. Duran-Aniotz, C., Moreno-Gonzalez, I., Medinas, D. B., Morales, R. Front Aging Neurosci. 2022 Feb 9;13:830779. doi: 10.3389/fnagi.2021.830779. PMID: 35221985; PMCID: PMC8864239.

• Aged Cattle Brain Displays Alzheimer’s Disease-Like Pathology and Promotes Brain Amyloidosis in a Transgenic Animal Model. Moreno-Gonzalez, I., Edwards, G., Morales, R., Duran-Aniotz, C., Escobedo, G., Marquez, M., Pumarola, M., Soto, C. Front Aging Neurosci. 2022 Jan 31;13:815361. doi: 10.3389/fnagi.2021.815361. PMID: 35173603; PMCID: PMC8841674.

• Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis. Ogonowski, N., Salcidua, S., Leon, T., Chamorro-Veloso, N., Valls, C., Avalos, C., Bisquertt, A., Rentería, M. E., Orellana, P., Duran-Aniotz, C. Front Aging Neurosci. 2022 Jan 12;13:807764. doi: 10.3389/fnagi.2021.807764. PMID: 35095478; PMCID: PMC8790149.

• Reconsideración de los aportes de Humberto Maturana para los desafíos actuales de las neurociencias cognitivas. Migeot, J. , Durán-Aniotz, C., Ibáñez, A. Estudios Públicos 163 (2021), 149-158 doi: 10.38178/07183089/1056210709

• Systematic Review: Genetic, Neuroimaging, and Fluids Biomarkers for Frontotemporal Dementia Across Latin America Countries. Duran-Aniotz, C., Orellana, P., Leon Rodriguez, T., Henriquez, F., Cabello, V., Aguirre-Pinto, M.F., Escobedo, T., Takada, L.T., Pina-Escudero, S.D., Lopez, O., Yokoyama, J.S., Ibanez, A., Parra, M.A, Slachevsky, A. Front Neurol. 2021 Jun 24;12:663407. doi: 10.3389/fneur.2021.663407. PMID: 34248820; PMCID: PMC8263937.

• Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer’s Disease Are Linked with Neurotransmitter Alterations. Araya-Arriagada, J., Bello, F., Shivashankar, G., Neira, D., Duran-Aniotz, C., Acosta, M.L., Escobar, M.J., Hetz, C., Chacón, M., Palacios, A.G. J Alzheimers Dis. 2021;82(s1):S5-S18. doi: 10.3233/JAD-201195. PMID: 33749647.

• DEF8 and Autophagy-Associated Genes Are Altered in Mild Cognitive Impairment, Probable Alzheimer’s Disease Patients, and a Transgenic Model of the Disease. Leyton, E., Matus, D., Espinoza, S., Benitez, J.M., Cortés, B.I., Gomez, W., Arévalo, N.B., Murgas, P., Manque, P., Woehlbier, U., Duran-Aniotz, C., Hetz, C., Behrens, M.I., SanMartín, C.D., Nassif, M. J Alzheimers Dis. 2021;82(s1):S163-S178. doi: 10.3233/JAD-201264. PMID: 33612542.

• Transmission of cerebral amyloid pathology by peripheral administration of misfolded Aβ aggregates. Morales, R., Bravo-Alegria, J., Moreno-Gonzalez, I., Duran-Aniotz, C., Gamez, N., Edwards Iii, G., Soto, C. Mol Psychiatry. 2021 Oct;26(10):5690-5701. doi: 10.1038/s41380-021-01150-w. Epub 2021 May 17. PMID: 34002023; PMCID: PMC8595465.

• Amyloid pathology arrangements in Alzheimer’s disease brains modulate in vivo seeding capability. Duran-Aniotz, C., Moreno-Gonzalez, I., Gamez, N., Perez-Urrutia, N., Vegas-Gomez, L., Soto, C., Morales, R. Acta Neuropathol Commun. 2021 Mar 30;9(1):56. doi: 10.1186/s40478-021-01155-0. PMID: 33785065; PMCID: PMC8008576.

• The Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat): Driving Multicentric Research and Implementation Science. Ibanez, A., Yokoyama, J.S., Possin, K.L., Matallana, D., Lopera, F., Nitrini, R., Takada, L.T., Custodio, N., Sosa Ortiz, A.L., Avila-Funes, J.A., Behrens, M.I., Slachevsky, A., Myers, R.M., Cochran, J.N., Brusco, L.I., Bruno, M.A., Brucki, S.M.D., Pina-Escudero, S.D., Okada de Oliveira, M., Donnelly Kehoe, P., Garcia, A.M., Cardona, J.F., Santamaria-Garcia, H., Moguilner, S., Duran-Aniotz, C., Tagliazucchi, E., Maito, M., Longoria Ibarrola, E.M., Pintado-Caipa, M., Godoy, M.E., Bakman, V., Javandel, S., Kosik, K.S., Valcour, V., Miller, B.L. Front Neurol. 2021 Mar 11;12:631722. doi: 10.3389/fneur.2021.631722. PMID: 33776890; PMCID: PMC7992978.

• Infusion of blood from mice displaying cerebral amyloidosis accelerates amyloid pathology in animal models of Alzheimer’s disease. Morales R, Duran-Aniotz C, Bravo-Alegria J, Estrada LD, Shahnawaz M, Hu PP, Kramm C, Morales-Scheihing D, Urayama A, Soto C. Acta Neuropathol Commun. 2020 Dec 7;8(1):213. doi: 10.1186/s40478-020-01087-1. PMID: 33287898; PMCID: PMC7720397.

• The impact of SARS-CoV-2 in dementia across Latin America: A call for an urgent regional plan and coordinated response. Ibanez A, Santamaria-Garcia H, Guerrero Barragan A, Kornhuber A, Ton AMM, Slachevsky A, Teixeira AL, Mar Meza BM, Serrano CM, Cano C, Arias Gonzalez C, Gonzalez-Billault C, Butler C, Bustin J, Duran-Aniotz C, Acosta D, Matallana DL, Acosta-Alvear D, Trépel D, Resende EPF, de Oliveira FF, Ibanez F, De Felice FG, Navarrete G, Tarnanas I, Meier IB, Smid J, Llibre-Guerra J, Llibre-Rodriguez JJ, Fajersztajn L, Takada LT, Duque L, Okada de Oliveira M, Bicalho MAC, Behrens MI, Pintado-Caipa M, Parra M, Wilson MZ, De La Cruz Puebla M, Custodio N, Santibanez R, Serafim RB, Tavares RM, Piña Escudero SD, Leon Rodriguez T, Dawson W, Miller BL, Kosik KS. Alzheimers Dement (N Y). 2020 Nov 23;6(1):e12092. doi: 10.1002/trc2.12092. PMID: 33283036; PMCID: PMC7683959.

• GERO Cohort Protocol, Chile, 2017-2022: Community-based Cohort of Functional Decline in Subjective Cognitive Complaint elderly. Slachevsky A, Zitko P, Martínez-Pernía D, Forno G, Court FA, Lillo P, Villagra R, Duran-Aniotz C, Parrao T, Assar R, Orellana P, Toledo C, Rivera R, Ibañez A, Parra MA, González-Billault C, Amieva H, Thumala D. BMC Geriatr. 2020 Nov 25;20(1):505. doi: 10.1186/s12877-020-01866-4. PMID: 33238908; PMCID: PMC7690082.

• Unfolded protein response as a target in the treatment of Alzheimer’s disease. Rivera-Krstulović C, Duran-Aniotz C. Rev Med Chil. 2020 Feb;148(2):216-223. Spanish. doi: 10.4067/s0034-98872020000200216. PMID: 32730499.

• Acute Pannexin 1 Blockade Mitigates Early Synaptic Plasticity Defects in a Mouse Model of Alzheimer’s Disease. Flores-Muñoz C, Gómez B, Mery E, Mujica P, Gajardo I, Córdova C, Lopez-Espíndola D, Durán-Aniotz C, Hetz C, Muñoz P, Gonzalez-Jamett AM, Ardiles ÁO. Front Cell Neurosci. 2020 Mar 19;14:46. doi: 10.3389/fncel.2020.00046. PMID: 32265655; PMCID: PMC7103637.

• Endoplasmic reticulum proteostasis impairment in aging. Martínez G, Duran-Aniotz C, Cabral-Miranda F, Vivar JP, Hetz C. Aging Cell. 2017 Aug;16(4):615-623. doi: 10.1111/acel.12599. Epub 2017 Apr 23. PMID: 28436203; PMCID: PMC5506418. Feb;148(2):216-223. Spanish. doi: 10.4067/s0034-98872020000200216. PMID: 32730499.

• IRE1 signaling exacerbates Alzheimer’s disease pathogenesis. Duran-Aniotz C, Cornejo VH, Espinoza S, Ardiles ÁO, Medinas DB, Salazar C, Foley A, Gajardo I, Thielen P, Iwawaki T, Scheper W, Soto C, Palacios AG, Hoozemans JJM, Hetz C. Acta Neuropathol. 2017 Sep;134(3):489-506. doi: 10.1007/s00401-017-1694-x. Epub 2017 Mar 24. PMID: 28341998.

• Glucose Metabolism: A Sweet Relief of Alzheimer’s Disease. Duran-Aniotz C, Hetz C. Curr Biol. 2016 Sep 12;26(17):R806-9. doi: 10.1016/j.cub.2016.07.060. PMID: 27623263.

• Commentary: XBP-1 Is a Cell-Nonautonomous Regulator of Stress Resistance and Longevity. Martínez G, Duran-Aniotz C, Cabral-Miranda F, Hetz C. Front Aging Neurosci. 2016 Aug 3;8:182. doi: 10.3389/fnagi.2016.00182. PMID: 27534903; PMCID: PMC4971125.

• Gene therapy to target ER stress in brain diseases. Valenzuela V, Martínez G, Duran-Aniotz C, Hetz C. Brain Res. 2016 Oct 1;1648(Pt B):561-570. doi: 10.1016/j.brainres.2016.04.064. Epub 2016 Apr 27. PMID: 27131987.

• Role of Prion Replication in the Strain-dependent Brain Regional Distribution of Prions. Hu PP, Morales R, Duran-Aniotz C, Moreno-Gonzalez I, Khan U, Soto C. J Biol Chem. 2016 Jun 10;291(24):12880-12887. doi: 10.1074/jbc.M115.681791. Epub 2016 Apr 7. PMID: 27056328; PMCID: PMC4933468.

• Targeting endoplasmic reticulum acetylation to restore proteostasis in Alzheimer’s disease. Duran-Aniotz C, Cornejo VH, Hetz C. Brain. 2016 Mar;139(Pt 3):650-2. doi: 10.1093/brain/awv401. PMID: 26917585.

• Strain-dependent profile of misfolded prion protein aggregates. Morales R, Hu PP, Duran-Aniotz C, Moda F, Diaz-Espinoza R, Chen B, Bravo-Alegria J, Makarava N, Baskakov IV, Soto C. Sci Rep. 2016 Feb 15;6:20526. doi: 10.1038/srep20526. PMID: 26877167; PMCID: PMC4753423.

• Titration of biologically active amyloid-β seeds in a transgenic mouse model of Alzheimer’s disease. Morales R, Bravo-Alegria J, Duran-Aniotz C, Soto C. Sci Rep. 2015 Mar 23;5:9349. doi: 10.1038/srep09349. PMID: 25879692; PMCID: PMC4399520.

• ER stress signaling and neurodegeneration: At the intersection between Alzheimer’s disease and Prion-related disorders. Torres M, Matamala JM, Duran-Aniotz C, Cornejo VH, Foley A, Hetz C. Virus Res. 2015 Sep 2;207:69-75. doi: 10.1016/j.virusres.2014.12.018. Epub 2014 Dec 31. PMID: 25556124.

• Aggregate-depleted brain fails to induce Aβ deposition in a mouse model of Alzheimer’s disease. Duran-Aniotz C, Morales R, Moreno-Gonzalez I, Hu PP, Fedynyshyn J, Soto C. PLoS One. 2014 Feb 12;9(2):e89014. doi: 10.1371/journal.pone.0089014. PMID: 24533166; PMCID: PMC3923072.

• Memory loss in Alzheimer’s disease: are the alterations in the UPR network involved in the cognitive impairment?. Duran-Aniotz C, Martínez G, Hetz C. Front Aging Neurosci. 2014 Jan 30;6:8. doi: 10.3389/fnagi.2014.00008. PMID: 24523695; PMCID: PMC3906588.

• Brains from non-Alzheimer’s individuals containing amyloid deposits accelerate Aβ deposition in vivo. Duran-Aniotz C, Morales R, Moreno-Gonzalez I, Hu PP, Soto C. Acta Neuropathol Commun. 2013 Nov 18;1(1):76. doi: 10.1186/2051-5960-1-76. PMID: 24252208; PMCID: PMC4046659.

• Lack of prion transmission by sexual or parental routes in experimentally infected hamsters. Morales R, Pritzkow S, Hu PP, Duran-Aniotz C, Soto C. Prion. 2013 Sep-Oct;7(5):412-9. doi: 10.4161/pri.26747. Epub 2013 Oct 11. PMID: 24121659; PMCID: PMC4134346.

• Amyloid aggregates: role in Protein Misfolding Disorders. Duran-Aniotz C, Moreno-Gonzalez I, Morales R. Rev Med Chil. 2013 Apr;141(4):495-505. Spanish. doi: 10.4067/S0034-98872013000400011. PMID: 23900371.

• The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses. Durán-Aniotz C, Segal G, Salazar L, Pereda C, Falcón C, Tempio F, Aguilera R, González R, Pérez C, Tittarelli A, Catalán D, Nervi B, Larrondo M, Salazar-Onfray F, López MN. Cancer Immunol Immunother. 2013 Apr;62(4):761-72. doi: 10.1007/s00262-012-1377-3. Epub 2012 Dec 15. PMID: 23242374.

• Protein misfolding cyclic amplification of infectious prions. Morales R, Duran-Aniotz C, Diaz-Espinoza R, Camacho MV, Soto C. Nat Protoc. 2012 Jun 28;7(7):1397-409. doi: 10.1038/nprot.2012.067. PMID: 22743831; PMCID: PMC4049227.

• De novo induction of amyloid-β deposition in vivo. Morales R, Duran-Aniotz C, Castilla J, Estrada LD, Soto C. Mol Psychiatry. 2012 Dec;17(12):1347-53. doi: 10.1038/mp.2011.120. Epub 2011 Oct 4. PMID: 21968933.